The effect of tezepelumab in patients with allergic asthma: Results from the PATHWAY phase IIb study

被引：0
作者：
Corren, J. [1 ]
Colice, G. [2 ]
Salapa, K. [3 ]
Bowen, K. [4 ]
Llanos-Ackert, J. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] AstraZeneca, San Francisco, CA USA
[3] AstraZeneca, Warsaw, Poland
[4] AstraZeneca, Gaithersburg, MD USA
[5] Amgen Inc, Gaithersburg, MD USA
来源：
ALLERGY | 2020年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1105
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
[41]   Tezepelumab Reduces Multiple Key Inflammatory Biomarkers in Patients with Severe, Uncontrolled Asthma in the Phase 2b PATHWAY Study [J].
Pham, T. ;
Ren, P. ;
Parnes, J. R. ;
Griffiths, J. M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[42]   Switching to tezepelumab from other biologics in patients with severe asthma: a retrospective study [J].
Sumi, Toshiyuki ;
Ishigooka, Taiki ;
Matsuura, Keigo ;
Ikeda, Takumi ;
Koshino, Yuta ;
Suzuki, Keito ;
Yamada, Yuichi ;
Chiba, Hirofumi .
RESPIRATORY INVESTIGATION, 2025, 63 (04) :592-599
[43]   Effect Of Tezepelumab On Fatigue In Patients With Severe, Uncontrolled Asthma And Chronic Rhinosinusitis With Nasal Polyps In The Phase 3 NAVIGATOR Study [J].
Jacobs, Joshua ;
Hoyte, Flavia ;
Han, Joseph ;
Martin, Nicole ;
Caveney, Scott ;
Foster, Andrew ;
Ambrose, Chris .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) :AB75-AB75
[44]   Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma With Aspirin-exacerbated Respiratory Disease: Results From the NAVIGATOR Study [J].
Bernstein, Jonathan ;
Laidlaw, Tanya ;
Buccheit, Kathleen ;
Cahill, Katherine ;
Martin, Nicole ;
Ponnarambil, Sandhia ;
Parikh, Bhavini ;
Ambrose, Christopher ;
Lindsley, Andrew .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) :AB101-AB101
[45]   Allergic bronchopulmonary aspergillosis in patients with asthma: Results of a prospective study [J].
Kozlova, Ya. L. ;
Frolova, E. V. ;
Filippova, L. V. ;
Uchevatkina, A. E. ;
Aak, O. V. ;
Klimko, N. N. .
TERAPEVTICHESKII ARKHIV, 2017, 89 (08) :13-16
[46]   Tezepelumab Reduces and Eliminates OCS Use in OCS-Dependent Patients With Severe Asthma: Primary Results From the Phase 3b WAYFINDER Study [J].
Jackson, D. J. ;
Lugogo, N. ;
Gurnell, M. ;
Heaney, L. G. ;
Korn, S. ;
Brusselle, G. ;
Chanez, P. ;
del Olmo, R. ;
Llanos, J. ;
Keeling, N. ;
Salapa, K. ;
Cook, B. ;
Kostikas, K. ;
Fogel, R. ;
Martin, N. ;
Chandarana, S. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2025, 211
[47]   TEZEPELUMAB PRODUCES CLINICALLY MEANINGFUL RESPONSES ON PATIENT-REPORTED OUTCOME MEASURES IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY [J].
Lugogo, Njira ;
Ponnarambil, Sandhia ;
Ambrose, Christopher ;
Cook, William ;
Hunter, Gillian ;
Llanos-Ackert, Jean-Pierre ;
Corren, Jonathan .
CHEST, 2021, 160 (04) :44A-47A
[48]   Effect of Tezepelumab on Airway Hyperresponsiveness by Baseline Blood Eosinophil Count in Patients With Severe, Uncontrolled Asthma in the Phase 2 CASCADE Study [J].
Brightling, C. E. ;
O'Byrne, P. M. ;
Porsbjerg, C. ;
Boulet, L. ;
Martin, N. ;
Molfino, N. A. ;
Megally, A. ;
Griffiths, J. M. ;
Clarke, D. ;
Martin, N. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[49]   EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND ALLERGIC RHINITIS GROUPED BY BASELINE BLOOD EOSINOPHIL COUNT: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR [J].
Wechsler, Michael E. ;
Chupp, Geoffrey L. ;
Israel, Elliot ;
Castro, Mario ;
Bober, Magdalena ;
Lindsley, Andrew ;
Spahn, Joe D. ;
Ambrose, Christopher S. .
CHEST, 2024, 166 (04) :4664A-4680A
[50]   Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study [J].
Emson, Claire ;
Corren, Jonathan ;
Salapa, Kinga ;
Hellqvist, Asa ;
Parnes, Jane R. ;
Colice, Gene .
JOURNAL OF ASTHMA AND ALLERGY, 2021, 14 :91-99
12345